{"altmetric_id":3723257,"counts":{"readers":{"mendeley":25,"citeulike":0,"connotea":0},"facebook":{"unique_users_count":2,"unique_users":["279266535526036","164704757014874"],"posts_count":2},"googleplus":{"unique_users_count":1,"unique_users":["Sridhar Hariharaputran"],"posts_count":1},"total":{"posts_count":24},"twitter":{"unique_users_count":20,"unique_users":["BibCCBSUFCG","OnCritical","EpigenChromatin","UESSRR","sumitpareek9","jet_milton","LakePharma","Aisha12895124","a_vikram","BioMedCentral","PD_value","oncologiavet","Itsme_theKing","Dr_BoAbrahamsen","emas_online","OAgenetics","nRICHd_Pursuits","Gabri_Elle76","epigen_papers","CancerWallonia"],"posts_count":21}},"selected_quotes":["#Epigenetic inhibitors can alter the transcriptomes of tumours - full","New in Epigenetics Chromatin: How epigenomic inhibitors alter #cancer transcriptomes","#Altering #cancer #transcriptomes using #epigenomic #inhibitors (followed by Marc #Lacroix) #epigeneticschromatin"],"citation":{"abstract":"Due to the hyper-activation of WNT signaling in a variety of cancer types, there has been a strong drive to develop pathway-specific inhibitors with the eventual goal of providing a chemotherapeutic antagonist of WNT signaling to cancer patients. A new category of drugs, called epigenetic inhibitors, are being developed that hold high promise for inhibition of the WNT pathway. The canonical WNT signaling pathway initiates when WNT ligands bind to receptors, causing the nuclear localization of the co-activator \u03b2-catenin (CTNNB1), which leads to an association of \u03b2-catenin with a member of the TCF transcription factor family at regulatory regions of WNT-responsive genes. The TCF\/\u03b2-catenin complex then recruits CBP (CREBBP) or p300 (EP300), leading to histone acetylation and gene activation. A current model in the field is that CBP-driven expression of WNT target genes supports proliferation whereas p300-driven expression of WNT target genes supports differentiation. The small molecule inhibitor ICG-001 binds to CBP, but not to p300, and competitively inhibits the interaction of CBP with \u03b2-catenin. Upon treatment of cancer cells, this should reduce expression of CBP-regulated transcription, leading to reduced tumorigenicity and enhanced differentiation.\nWe have compared the genome-wide effects on the transcriptome after treatment with ICG-001 (the specific CBP inhibitor) versus C646, a compound that competes with acetyl-coA for the Lys-coA binding pocket of both CBP and p300. We found that both drugs cause large-scale changes in the transcriptome of HCT116 colon cancer cells and PANC1 pancreatic cancer cells and reverse some tumor-specific changes in gene expression. Interestingly, although the epigenetic inhibitors affect cell cycle pathways in both the colon and pancreatic cancer cell lines, the WNT signaling pathway was affected only in the colon cancer cells. Notably, WNT target genes were similarly downregulated after treatment of HCT116 with C646 as with ICG-001.\nOur results suggest that treatment with a general HAT inhibitor causes similar effects on the transcriptome as does treatment with a CBP-specific inhibitor and that epigenetic inhibition affects the WNT pathway in HCT116 cells and the cholesterol biosynthesis pathway in PANC1 cells.","altmetric_jid":"4f6fa4d03cf058f610000815","authors":["Malaina Gaddis","Diana Gerrard","Seth Frietze","Peggy J Farnham"],"doi":"10.1186\/1756-8935-8-9","first_seen_on":"2015-02-24T10:43:31+00:00","funders":["niehs","nci","nigms"],"issns":["1756-8935"],"issue":"1","journal":"Epigenetics & Chromatin","last_mentioned_on":1437555587,"links":["http:\/\/www.epigeneticsandchromatin.com\/content\/8\/1\/9\/abstract","http:\/\/www.epigeneticsandchromatin.com\/content\/pdf\/1756-8935-8-9.pdf","http:\/\/www.epigeneticsandchromatin.com\/content\/8\/1\/9?utm_source=dlvr.it&utm_medium=facebook","http:\/\/www.epigeneticsandchromatin.com\/content\/8\/1\/9\/abstract?utm_content=bufferd98e2&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26191083?dopt=Abstract&utm_source=dlvr.it&utm_medium=twitter","http:\/\/www.epigeneticsandchromatin.com\/content\/8\/1\/9"],"pdf_url":"http:\/\/www.epigeneticsandchromatin.com\/content\/pdf\/1756-8935-8-9.pdf","pmid":"26191083","pubdate":"2015-02-24T00:00:00+00:00","publisher":"BioMed Central Ltd","publisher_subjects":[{"name":"Genetics","scheme":"era"}],"startpage":"9","title":"Altering cancer transcriptomes using epigenomic inhibitors","type":"article","volume":"8","mendeley_url":"http:\/\/www.mendeley.com\/research\/altering-cancer-transcriptomes-using-epigenomic-inhibitors"},"altmetric_score":{"score":12.1,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":12.1},"context_for_score":{"all":{"total_number_of_other_articles":5387274,"mean":6.2932027265005,"rank":438333,"this_scored_higher_than_pct":91,"this_scored_higher_than":4947835,"rank_type":"exact","sample_size":5387274,"percentile":91},"similar_age_3m":{"total_number_of_other_articles":158357,"mean":10.067944643714,"rank":20498,"this_scored_higher_than_pct":87,"this_scored_higher_than":137794,"rank_type":"exact","sample_size":158357,"percentile":87},"this_journal":{"total_number_of_other_articles":189,"mean":6.7750531914894,"rank":26,"this_scored_higher_than_pct":86,"this_scored_higher_than":163,"rank_type":"exact","sample_size":189,"percentile":86},"similar_age_this_journal_3m":{"total_number_of_other_articles":10,"mean":12.261111111111,"rank":6,"this_scored_higher_than_pct":40,"this_scored_higher_than":4,"rank_type":"exact","sample_size":10,"percentile":40}}},"demographics":{"poster_types":{"member_of_the_public":16,"researcher":3,"science_communicator":1},"users":{"twitter":{"cohorts":{"Members of the public":14,"Science communicators (journalists, bloggers, editors)":2,"Scientists":4}},"mendeley":{"by_status":{"Professor > Associate Professor":2,"Researcher":7,"Student  > Doctoral Student":1,"Student  > Ph. D. Student":9,"Student  > Postgraduate":1,"Student  > Master":4,"Professor":1},"by_discipline":{"Medicine and Dentistry":3,"Neuroscience":2,"Immunology and Microbiology":2,"Agricultural and Biological Sciences":12,"Computer Science":1,"Biochemistry, Genetics and Molecular Biology":3,"Unspecified":1,"Environmental Science":1}}},"geo":{"twitter":{"GB":4,"IN":1,"US":4,"EG":1,"DK":1,"CH":1,"AU":1,"FR":1},"mendeley":{"BE":1,"US":1}}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/BibCCBSUFCG\/status\/570172124222119936","license":"datasift","citation_ids":[3723257],"posted_on":"2015-02-24T10:43:22+00:00","author":{"name":"Biblioteca CCBS-UFCG","url":"http:\/\/bibliotecaccbs.strikingly.com","image":"https:\/\/pbs.twimg.com\/profile_images\/482133107114397696\/8xBpB52X_normal.jpeg","id_on_source":"BibCCBSUFCG","tweeter_id":"2458056060","geo":{"lt":null,"ln":null},"followers":14},"tweet_id":"570172124222119936"},{"url":"https:\/\/twitter.com\/BibCCBSUFCG\/status\/570172172544516096","license":"datasift","citation_ids":[3723257],"posted_on":"2015-02-24T10:43:33+00:00","author":{"name":"Biblioteca CCBS-UFCG","url":"http:\/\/bibliotecaccbs.strikingly.com","image":"https:\/\/pbs.twimg.com\/profile_images\/482133107114397696\/8xBpB52X_normal.jpeg","id_on_source":"BibCCBSUFCG","tweeter_id":"2458056060","geo":{"lt":null,"ln":null},"followers":14},"tweet_id":"570172172544516096"},{"url":"https:\/\/twitter.com\/OnCritical\/status\/570195018364821504","license":"datasift","citation_ids":[3723257],"posted_on":"2015-02-24T12:14:20+00:00","author":{"name":"By: Om\u00e1r","image":"https:\/\/pbs.twimg.com\/profile_images\/694684740410953728\/yN96TapT_normal.jpg","description":"Iuris, Iustitia et a Lex. | News, Trends, Politics, Opinion, Economy and Opportunities. | Noticias, Tendencias, Pol\u00edtica, Opini\u00f3n, Econom\u00eda y Oportunidades","id_on_source":"OnCritical","tweeter_id":"76849213","geo":{"lt":null,"ln":null},"followers":255},"tweet_id":"570195018364821504"},{"url":"https:\/\/twitter.com\/EpigenChromatin\/status\/570227692085256193","license":"datasift","citation_ids":[3723257],"posted_on":"2015-02-24T14:24:10+00:00","author":{"name":"EpigeneticsChromatin","url":"http:\/\/www.epigeneticsandchromatin.com","image":"https:\/\/pbs.twimg.com\/profile_images\/694842142284500992\/JebYpffe_normal.png","description":"Epigenetics & Chromatin publishes articles that provide novel insights into epigenetic inheritance and chromatin-based interactions.","id_on_source":"EpigenChromatin","tweeter_id":"562100356","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":3077},"tweet_id":"570227692085256193"},{"url":"https:\/\/twitter.com\/UESSRR\/status\/570242586893398018","license":"datasift","rt":["EpigenChromatin"],"citation_ids":[3723257],"posted_on":"2015-02-24T15:23:21+00:00","author":{"name":"Yocto-domtado","image":"https:\/\/pbs.twimg.com\/profile_images\/471832229832704000\/G2ag7H_i_normal.jpeg","id_on_source":"UESSRR","tweeter_id":"156634139","geo":{"lt":null,"ln":null},"followers":352},"tweet_id":"570242586893398018"},{"url":"https:\/\/twitter.com\/sumitpareek9\/status\/570267163329568768","license":"datasift","rt":["BioMedCentral"],"citation_ids":[3723257],"posted_on":"2015-02-24T17:01:01+00:00","author":{"name":"Sumit Pareek","url":"http:\/\/Easysci.WordPress.com","image":"https:\/\/pbs.twimg.com\/profile_images\/643457302922571777\/8cnyQnwW_normal.jpg","description":"Science #Blogger, #Article Writer #Motivater","id_on_source":"sumitpareek9","tweeter_id":"171784218","geo":{"lt":"27.6652083","ln":"75.0237988175519","country":"IN"},"followers":73},"tweet_id":"570267163329568768"},{"url":"https:\/\/twitter.com\/jet_milton\/status\/570267480196644864","license":"datasift","rt":["BioMedCentral"],"citation_ids":[3723257],"posted_on":"2015-02-24T17:02:16+00:00","author":{"name":"Eduardo Milton","image":"https:\/\/pbs.twimg.com\/profile_images\/1516831647\/a627885033_5764103_1974_normal.jpg","description":"Scientist & rueful hedonist, peripathetic hypochondriac, fl\u00e2neur, oneiroclast, dispersed & fluently confused... i play in the places where i used to ache.","id_on_source":"jet_milton","tweeter_id":"363438908","geo":{"lt":40.71427,"ln":-74.00597,"country":"US"},"followers":783},"tweet_id":"570267480196644864"},{"url":"https:\/\/twitter.com\/LakePharma\/status\/570268440411246592","license":"datasift","rt":["BioMedCentral"],"citation_ids":[3723257],"posted_on":"2015-02-24T17:06:05+00:00","author":{"name":"LakePharma","url":"http:\/\/www.lakepharma.com","image":"http:\/\/pbs.twimg.com\/profile_images\/577867432536068096\/6jzwbL7w_normal.jpeg","description":"LakePharma is a leading contract research organization (CRO) specializing in antibody and protein engineering, cell line development, and protein production.","id_on_source":"LakePharma","tweeter_id":"199980641","geo":{"lt":"37.516033","ln":"-122.297861725643","country":"US"},"followers":59},"tweet_id":"570268440411246592"},{"url":"https:\/\/twitter.com\/Aisha12895124\/status\/570273533655265280","license":"datasift","rt":["BioMedCentral"],"citation_ids":[3723257],"posted_on":"2015-02-24T17:26:20+00:00","author":{"name":"Aisha","image":"https:\/\/pbs.twimg.com\/profile_images\/486493971594489856\/ayrqxkjE_normal.jpeg","id_on_source":"Aisha12895124","tweeter_id":"1223478822","geo":{"lt":30.9,"ln":31,"country":"EG"},"followers":2546},"tweet_id":"570273533655265280"},{"url":"https:\/\/twitter.com\/a_vikram\/status\/570286619917475840","license":"datasift","rt":["BioMedCentral"],"citation_ids":[3723257],"posted_on":"2015-02-24T18:18:20+00:00","author":{"name":"Amit Vikram","url":"http:\/\/about.me\/avikram","image":"https:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_normal.png","description":"Microbiome expert","id_on_source":"a_vikram","tweeter_id":"102749794","geo":{"lt":40.58612,"ln":-98.38839,"country":"US"},"followers":34},"tweet_id":"570286619917475840"},{"url":"https:\/\/twitter.com\/BioMedCentral\/status\/570266942285750272","license":"datasift","citation_ids":[3723257],"posted_on":"2015-02-24T17:00:08+00:00","author":{"name":"BMC","url":"http:\/\/www.biomedcentral.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/888016438174339073\/foekpiRD_normal.jpg","description":"A pioneer of sustainable open access, where research is always in progress. Tweets by @DannoCaley","id_on_source":"BioMedCentral","tweeter_id":"41561657","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":47269},"tweet_id":"570266942285750272"},{"url":"https:\/\/twitter.com\/PD_value\/status\/570308355094413312","license":"datasift","rt":["BioMedCentral"],"citation_ids":[3723257],"posted_on":"2015-02-24T19:44:42+00:00","author":{"name":"PD-value","url":"http:\/\/pd-value.com","image":"https:\/\/pbs.twimg.com\/profile_images\/494978993955696640\/pdaFKe7-_normal.png","description":"Provider in pharmacometrics. Broad experience in translational approaches and partner in early clinical development. \njeroen@pd-value.com \n+31623118438","id_on_source":"PD_value","tweeter_id":"2602425384","geo":{"lt":null,"ln":null},"followers":92},"tweet_id":"570308355094413312"},{"url":"https:\/\/twitter.com\/oncologiavet\/status\/570351102584950785","license":"datasift","citation_ids":[3723257],"posted_on":"2015-02-24T22:34:34+00:00","author":{"name":"Oncologiavet","url":"https:\/\/twitter.com\/oncologiavet","image":"https:\/\/pbs.twimg.com\/profile_images\/849456038709538817\/jJ9c5Y2Q_normal.jpg","description":"Francisco Alvarez Berger DVM MSc DACVIM (Oncology) - Veterinary oncology","id_on_source":"oncologiavet","tweeter_id":"167392151","geo":{"lt":39.76,"ln":-98.5,"country":"US"},"followers":4482},"tweet_id":"570351102584950785"},{"url":"https:\/\/twitter.com\/Itsme_theKing\/status\/570395189979652096","license":"datasift","rt":["BioMedCentral"],"citation_ids":[3723257],"posted_on":"2015-02-25T01:29:45+00:00","author":{"name":"Arun M","image":"http:\/\/pbs.twimg.com\/profile_images\/1849761161\/417368_277083005691223_100001685762447_752962_1103758680_n_me_normal.jpg","id_on_source":"Itsme_theKing","tweeter_id":"410492859","followers":112},"tweet_id":"570395189979652096"},{"url":"https:\/\/twitter.com\/Dr_BoAbrahamsen\/status\/570471478736621568","license":"datasift","rt":["BioMedCentral"],"citation_ids":[3723257],"posted_on":"2015-02-25T06:32:54+00:00","author":{"name":"Bo Abrahamsen","url":"http:\/\/findresearcher.sdu.dk\/portal\/en\/person\/babrahamsen","image":"https:\/\/pbs.twimg.com\/profile_images\/848951992995262465\/EQ1auB7O_normal.jpg","description":"Professor and endocrinologist, tweeting in a private capacity. Editor of this and that. Feed for researchers. Consult your doctor if you have health concerns.","id_on_source":"Dr_BoAbrahamsen","tweeter_id":"1328954563","geo":{"lt":56,"ln":10,"country":"DK"},"followers":815},"tweet_id":"570471478736621568"},{"url":"https:\/\/twitter.com\/emas_online\/status\/570485060958339072","license":"datasift","rt":["BioMedCentral"],"citation_ids":[3723257],"posted_on":"2015-02-25T07:26:52+00:00","author":{"name":"EMAS","url":"http:\/\/www.emas-online.org","image":"https:\/\/pbs.twimg.com\/profile_images\/2431611593\/ehog9vicc5qq013v0555_normal.png","description":"Our mission: promoting health for women and men in midlife and beyond","id_on_source":"emas_online","tweeter_id":"715923426","geo":{"lt":46.16667,"ln":6.16667,"country":"CH"},"followers":750},"tweet_id":"570485060958339072"},{"url":"https:\/\/twitter.com\/OAgenetics\/status\/570530963979051009","license":"datasift","rt":["EpigenChromatin"],"citation_ids":[3723257],"posted_on":"2015-02-25T10:29:16+00:00","author":{"name":"Genetics at BioMed","url":"http:\/\/www.biomedcentral.com","image":"https:\/\/pbs.twimg.com\/profile_images\/579966020418404352\/WJdxIRou_normal.png","description":"Home of the @BioMedCentral #openaccess genetics & genomics journals.","id_on_source":"OAgenetics","tweeter_id":"208572474","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":1574},"tweet_id":"570530963979051009"},{"url":"https:\/\/twitter.com\/nRICHd_Pursuits\/status\/570362282519056385","license":"datasift","rt":["BioMedCentral"],"citation_ids":[3723257],"posted_on":"2015-02-24T23:18:59+00:00","author":{"name":"enRICHed Pursuits","url":"http:\/\/www.enrichedpursuits.com","image":"https:\/\/pbs.twimg.com\/profile_images\/550837613842538497\/J2QzEjP0_normal.jpeg","description":"Science Communication under four streams | @Bio_nRICHd | @Cats_K9s | @Reprod_Devel | @SexSciSociety |\nManaging Director @DrNRichings","id_on_source":"nRICHd_Pursuits","tweeter_id":"476458078","geo":{"lt":-37.83333,"ln":144.96667,"country":"AU"},"followers":78},"tweet_id":"570362282519056385"},{"url":"https:\/\/twitter.com\/Gabri_Elle76\/status\/570520403099197440","license":"datasift","citation_ids":[3723257],"posted_on":"2015-02-25T09:47:18+00:00","author":{"name":"Gabriella Conti","url":"http:\/\/gabriellaconti.org","image":"https:\/\/pbs.twimg.com\/profile_images\/2315865724\/5qqn3trhidwnzp5qfezd_normal.gif","description":"Associate Professor in Economics at University College London","id_on_source":"Gabri_Elle76","tweeter_id":"209565427","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":251},"tweet_id":"570520403099197440"},{"url":"https:\/\/twitter.com\/epigen_papers\/status\/623487113237913600","license":"datasift","citation_ids":[3723257],"posted_on":"2015-07-21T13:38:06+00:00","author":{"name":"epigenetics_papers","url":"http:\/\/en.wikipedia.org\/wiki\/Epigenetics","image":"https:\/\/pbs.twimg.com\/profile_images\/471205704921931776\/wSQqKYz8_normal.jpeg","description":"Chromatin & epigenetics paper feed from #Pubmed and #Arxiv - hear it here first! Comments & suggestions welcome. Also http:\/\/t.co\/0Lque7l3ZD By @mariamdemidova","id_on_source":"epigen_papers","tweeter_id":"2526900595","geo":{"lt":48.11198,"ln":-1.67429,"country":"FR"},"followers":1863},"tweet_id":"623487113237913600"},{"url":"https:\/\/twitter.com\/CancerWallonia\/status\/623779461482348544","license":"datasift","citation_ids":[3723257],"posted_on":"2015-07-22T08:59:47+00:00","author":{"name":"CancerWallonia","image":"https:\/\/pbs.twimg.com\/profile_images\/623178120615604224\/unGEOij0_normal.jpg","description":"Cancer: from Wallonia to the World, from the World to Wallonia -  Cancer: la Wallonie parle au Monde, le Monde parle \u00e0 la Wallonie","id_on_source":"CancerWallonia","tweeter_id":"2848852120","geo":{"lt":null,"ln":null},"followers":602},"tweet_id":"623779461482348544"}],"googleplus":[{"title":"Altering cancer transcriptomes using epigenomic inhibitors","url":"https:\/\/plus.google.com\/107844782442337714025\/posts\/UCTSUpfMvSp","license":"public","citation_ids":[3723257],"posted_on":"2015-02-27T12:34:12+00:00","summary":"Altering cancer transcriptomes using epigenomic inhibitors Altering cancer transcriptomes using epigenomic inhibitors\ufeff Epigenetics & Chromatin | Abstract | Altering cancer transcriptomes using epigenomic inhibitors Due to the hyper-activation of WNT signal","author":{"name":"Sridhar Hariharaputran","url":"https:\/\/plus.google.com\/+SridharHariharaputran","image":"https:\/\/lh5.googleusercontent.com\/-Bt7J2mpP04U\/AAAAAAAAAAI\/AAAAAAAADbU\/g_K2IyZR5YM\/photo.jpg?sz=50","id_on_source":"107844782442337714025"}}],"facebook":[{"title":"Altering cancer transcriptomes using epigenomic inhibitors","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=730990330353652&id=279266535526036","license":"public","citation_ids":[3723257],"posted_on":"2015-02-24T10:43:21+00:00","summary":"Background: Due to the hyper-activation of WNT signaling in a variety of cancer types, there has been a strong drive to develop pathway-specific inhibitors with the eventual goal of providing a chemotherapeutic antagonist of WNT signaling to cancer patient","author":{"name":"Biblioteca Setorial Tereza Brasileiro Silva UFCG","url":"https:\/\/www.facebook.com\/279266535526036","facebook_wall_name":"Biblioteca Setorial Tereza Brasileiro Silva UFCG","image":"https:\/\/graph.facebook.com\/279266535526036\/picture","id_on_source":"279266535526036"}},{"title":"BioMed Central (@BioMedCentral) posted a photo on Twitter","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=471074479711232&id=164704757014874","license":"public","citation_ids":[3723257],"posted_on":"2015-02-24T23:19:04+00:00","summary":"Retweeted BioMed Central (@BioMedCentral):\n\n#Epigenetic inhibitors can alter the transcriptomes of tumours - full article: http:\/\/t.co\/w4UZiilDD3 http:\/\/t.co\/TaaXDlnJpA","author":{"name":"Enriched Pursuits","url":"https:\/\/www.facebook.com\/164704757014874","facebook_wall_name":"Enriched Pursuits","image":"https:\/\/graph.facebook.com\/164704757014874\/picture","id_on_source":"164704757014874"}}]}}